|
TEX264 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.159400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.699500E-02 |
| Normal-vs-Stage2 |
1.626380E-01 |
| Normal-vs-Stage3 |
6.368100E-02 |
| Normal-vs-Stage4 |
1.054550E-01 |
| Stage1-vs-Stage2 |
1.837760E-02 |
| Stage1-vs-Stage3 |
4.097600E-03 |
| Stage1-vs-Stage4 |
2.162400E-02 |
| Stage2-vs-Stage3 |
9.089400E-01 |
| Stage2-vs-Stage4 |
6.038200E-01 |
| Stage3-vs-Stage4 |
6.321400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.920000E-01 |
| Normal-vs-AfricanAmerican |
7.075200E-01 |
| Normal-vs-Asian |
5.557000E-01 |
| Caucasian-vs-AfricanAmerican |
2.666800E-01 |
| Caucasian-vs-Asian |
3.562000E-01 |
| AfricanAmerican-vs-Asian |
5.510000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.672600E-01 |
| Normal-vs-Female |
6.068200E-01 |
| Male-vs-Female |
1.579610E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.777000E-01 |
| Normal-vs-Extreme_Weight |
2.518200E-01 |
| Normal-vs-Obese |
9.522000E-01 |
| Normal-vs-Extreme_Obese |
6.127900E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.723600E-01 |
| Normal_Weight-vs-Obese |
8.496600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.061800E-02 |
| Extreme_Weight-vs-Obese |
3.436600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.160570E-01 |
| Obese-vs-Extreme_Obese |
7.007500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.012400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.111200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.747600E-01 |
| Normal-vs-Age(81-100Yrs) |
9.328600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.772400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.454400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.894400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.545400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.972600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.252200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.813800E-04 |
| Normal-VS-Type2 PRCC |
8.846800E-04 |
| Normal-VS-KIRP CIMP |
2.09860000000006E-05 |
| Normal-VS-Unclassified PRCC |
7.403000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.46719969507103E-10 |
| Type1 PRCC-VS-KIRP CIMP |
1.207160E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.142030E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.211390E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.670000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.225930E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.626400E-01 |
| Normal-vs-N1 |
7.56240000000519E-05 |
| Normal-vs-N2 |
8.472300E-02 |
| N0-vs-N1 |
9.763900E-04 |
| N0-vs-N2 |
4.107400E-01 |
| N1-vs-N2 |
3.947400E-01 |
|
|
